The Roots Analysis team is putting in its best effort to offer our clients / readers a reliable source of information, regarding how the pharmaceutical and biotech sectors are coping in the midst of the COVID-19 pandemic. Our intention is to generate realistic insights, based on a variety of factors, which are anticipated to influence both prevalent and future market dynamics. Reach out to us for any help.

Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030

  • Lowest Price Guaranteed From USD 4,499

  • Published
    February 2019

  • Pages
    230

  • View Count
    3782

Example Insights

 

Overview

For more than five decades, contact lenses have primarily been used to correct vision-related disorders. The existence of several unmet needs in the field of ophthalmology, recent technological advances and the availability of new biomaterials, have substantially expanded the range of potential application areas for contact lenses. It is estimated that close to 2.4 million eye injuries occur every year in the US. In order to cater to this demand, a myriad of therapeutic contact lenses have been developed specifically for treating / protecting the eye. The efficient delivery of drugs / other therapeutic substances to the eye is also deemed to be an area for improvement. It is presently characterized by low bioavailability and limited exposure time to pharmacological interventions; for instance, in the case of eye drops, 95% of the active therapeutic ingredient is assumed to be lost / wasted post dose administration. A variety of drug-eluting contact lenses have been / are being developed to address the aforementioned challenges. The potential of contact lenses is being explored for diagnosis and disease monitoring purposes as well. Diabetes and glaucoma are key clinical conditions for which contact lenses are being developed to assess and track various disease related parameters. In fact, 10 contact lenses have already been approved for purposes other than vision correction; recent examples include CUSTOMFLEX® ARTIFICIALIRIS (aniridia, 2018) and EYEMATE® (glaucoma, 2017).

On the other hand, according to the National Eye Institute, nearly 1.3 million people are blind, while 2.9 million individuals have poor vision, in the US. It is estimated that the number of cases for blindness and poor vision are likely to reach 2.2 million and 5 million, respectively, by 2030, in the same region. Visual prosthetics, such as bionic eyes, represent the next generation of solutions for vision restoration. Their unique mechanism of action leverages electrical pulses to stimulate optic nerves and bypass damaged segments of region in the eye. Pharmaceutical companies and academic institutions have already invested a significant amount of capital in the development and commercialization of the abovementioned products. The ongoing efforts to innovate in this domain are evident from the fact that more than 7,500 patents have been granted / filed since 2013. In the coming years, the market is anticipated to grow at a significant pace as more novel solutions clear clinical evaluation and get commercialized.

Scope of the Report

The “Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030” report features an extensive study of the current market landscape of therapeutic contact lenses, drug-eluting contact lenses, diagnostic / monitoring contact lenses and visual prostheses. The study lays emphasis on the novel products and technologies that are being developed for the treatment of ocular disorders, which generally cause severe visual impairment or blindness. Amongst other elements, the report includes:

  • A detailed review of the landscape of novel ophthalmic products, highlighting the different categories of contact lenses and visual prostheses (bionic eye technologies) developed / being developed by various players across the world. It features information on the purpose of development (therapeutic, drug delivery, and diagnosis / monitoring), current development status, target indication(s), type of product, type of organization (industry or non-industry) and location of company headquarters.
  • An analysis of the key promotional strategies that have been adopted by the developers of marketed products, namely ChromaGen™, CUSTOMFLEX® ARTIFICIALIRIS, EYEMATE®, Hyper-CL™, Implantable Miniature Telescope and SENSIMED Triggerfish®.
  • Brief profiles of the novel technologies that are being developed to expand the functionality of contact lenses; each profile features an overview of the technology, along with details on its working mechanism, information on application areas, type of products, key benefits, technical specifications and important details related to the developer company.
  • An in-depth analysis of the various patents granted / filed related to next generation contact lenses and visual prostheses since 2013, highlighting the prevalent and emerging related to the innovation in this domain. The analysis takes into consideration the type of patent, regional applicability, CPC classification, emerging focus areas, leading industry / non-industry players (in terms of the number of patents filed / granted), and patent valuation.
  • An analysis of the partnerships that have been established in this domain, covering R&D agreements, product development agreements, product commercialization agreements, service alliance and acquisitions; the analysis is based on multiple parameters, such as the type of agreement, type of organization, and focus area in terms of product application and target indication.
  • A study of prevalent and emerging trends, and the popularity of next generation contact lenses and visual prostheses, as observed on the social media platform, Twitter. The analysis takes into consideration the tweets posted on the platform, between 2013 and 2018 (till mid-October).
  • A list of key opinion leaders (KOLs) in this domain, featuring a 2X2 analysis to assess the relative experience of certain individuals, who were shortlisted based on their contributions (in terms of involvement in various clinical studies) to this field. It includes a schematic world map representation, highlighting the geographical locations of eminent scientists / researchers engaged in this domain. In addition, it presents an analysis assessing the credibility and (relative) level of expertise of different KOLs based on number of publications, number of citations, number of clinical trials, number of affiliations and extent of professional network.

One of the key objectives of the report was to determine the existing market size and develop estimates of future growth opportunities for next generation contact lenses and visual prostheses. Based on parameters, such as the target patient population, price of the lenses and the likely adoption rates, we have provided an informed estimate on the likely evolution of the market over the period 2019-2030. The report also features a detailed segmentation of the present and anticipated future opportunity based on [A] type of product (contact lenses and visual prostheses) [B] purpose of development of contact lenses (therapeutic, drug delivery and diagnosis / monitoring) [C] key disease indications (glaucoma, diabetes, AMD, retinitis pigmentosa and others) and [D] geography (North America, EU5 and Asia-Pacific). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely the conservative, base and optimistic scenarios, which represent different tracks of the industry’s evolution.

The opinions and insights presented in this study were also influenced by discussions conducted with several stakeholders in this domain. The report features detailed transcripts of interviews held with Mark E Byrne (Co-Founder and Chief Technical Officer, OcuMedic), Michal Shavit (Head of Sales and Marketing, EyeYon Medical and Praful Doshi (Founder, Chief Executive Officer and Chief Technical Officer, Leo Lens Technology).

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Contents

Chapter Outlines

Chapter 2 is an executive summary of the insights captured in our research. The summary offers a high-level view on the likely evolution of next generation contact lenses and visual prostheses market in the short term, mid term and long term.

Chapter 3 provides a general introduction to next generation ophthalmic lenses, highlighting the general concept of contact lenses along with the different types / classes of such products, along with their respective application areas. Further, it provides an overview of visual prostheses, describing the architecture and applications of such products. It also features a brief discussion on key therapeutic areas and the future of contact lenses.

Chapter 4 features a list of novel contact lenses that are developed / being developed for -therapeutic, drug delivery and diagnosis / monitoring purposes by both industry and non-industry players. It includes a list of visual prostheses that are either marketed or being developed by various companies. The chapter includes a detailed analysis of the aforementioned products based on various parameters, such as status of development, type of developer organization, location of headquarters (of the developer), target indication and type of product.

Chapter 5 highlights the key promotional strategies that are being implemented by the developers of marketed products, including ChromaGen™, CUSTOMFLEX® ARTIFICIALIRIS, EYEMATE®, Hyper-CL™, Implantable Miniature Telescope and SENSIMED Triggerfish®. The promotional aspects covered in the chapter include details that are provided on the product website (covering key messages for patients and healthcare professionals), patient support offerings and informative downloadable content.

Chapter 6 features brief profiles of novel technologies being developed by various industry, as well as non-industry players. Each profile presents an overview of the developer, key features of the technology, details on its working mechanism, and information on the area of application, type of product and advantages offered by the technology.

Chapter 7 provides an in-depth patent analysis, presenting an overview on the filed / granted patents related to next generation contact lenses and visual prostheses. For this analysis, we looked at the patents that have been published by various players since 2013. The analysis highlights the key information and trends associated with these patents, including patent type (granted patents, patent applications and others), patent publication year, regional distribution, CPC classification, emerging areas and leading industry / non-industry players. The chapter also includes a patent benchmarking and valuation analysis.

Chapter 8 features an analysis and discussion of the various collaborations and partnerships that have been inked amongst the players in this domain. It includes a brief description on the various types of partnership models (including product development agreements, product commercialization agreements, R&D agreements, service alliance and acquisitions) that have been adopted by stakeholders in this domain. The analysis highlights the prevailing trends with respect to the type of partnership, type of organization, and focus area in terms of product application and target indication. Furthermore, the chapter includes a world map representation of all the deals inked in this field, highlighting both intercontinental and intracontinental partnership activity.

Chapter 9 provides insights on the popularity of next generation contact lenses and visual prostheses on the social media platform, Twitter. For this analysis, we have analyzed tweets posted on the platform in the period between January 2013 and mid-October 2018. The chapter showcases the most frequently mentioned keywords / phrases and a bubble analysis of the most prolific and most influential authors, related to next generation contact lenses and visual prostheses, on Twitter.

Chapter 10 provides an analysis of KOLs in the field of next generation contact lenses and visual prostheses. It features a comprehensive list of principal investigators / study directors of different clinical trials, along with the information related to the affiliated research institutes. The chapter features a schematic representation on a world map, highlighting the geographical locations of eminent scientists / researchers who are engaged in clinical research in this domain. It also presents a comparative analysis, highlighting those KOLs who have relatively more experience in this domain. The credibility and (relative) level of expertise of different KOLs defined by other analysts / industry experts were compared to the results obtained using a proprietary scoring criteria, which was based on number of publications, number of citations, number of clinical trials, number of affiliations and extent of network.

Chapter 11 presents a comprehensive market forecast analysis, highlighting the future potential of next generation contact lenses and visual prostheses, till the year 2030. We have provided inputs on the likely opportunity on the basis of type of product (contact lenses and visual prostheses, purpose of development of contact lenses (therapeutic, drug delivery and diagnostic / monitoring), various target indications (glaucoma, diabetes, AMD, retinitis pigmentosa and others) and different regions (North America, EU5 and Asia-Pacific).

Chapter 12 summarizes the entire report. It presents a list of key takeaways and offers our independent opinion on the current market scenario. Further, it captures the evolutionary trends that are likely to determine the future of this segment of the industry.

Chapter 13 is a collection of interview transcripts of the discussions held with key stakeholders in the industry. In this chapter, we have presented the details of interviews held with Mark E. Byrne (Co-Founder and Chief Technical Officer, OcuMedic), Michal Shavit (Head of Sales and Marketing, EyeYon Medical) and Praful Doshi (Founder, Chief Executive Officer and Chief Technical Officer, Leo Lens Technology).

Chapter 14 is an appendix, which provides tabulated data and numbers for all the figures included in the report.

Chapter 15 is an appendix, which contains the list of companies and organizations that have been mentioned in the report.

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Context and Background
3.2. An Overview of Contact Lenses
3.2.1. Evolution of Contact Lenses
3.2.2. Applications of Contact Lenses
3.2.3. Types of Contact Lenses
3.2.4. Classification of Contact Lenses
3.2.4.1. Therapeutic Contact Lenses
3.2.4.2. Drug-Eluting Contact Lenses
3.2.4.2.1. Mechanism of Drug Delivery through Contact Lenses
3.2.4.2.2. Techniques for Developing Drug-Eluting Contact Lenses
3.2.4.3. Diagnostic / Monitoring Contact Lenses

3.3. Visual Prostheses
3.3.1. Architecture of a Bionic Eye
3.3.2. Working of a Bionic Eye
3.4. Key Therapeutic Indications
3.5. Prevalent Trends and Future Perspectives

4. MARKET OVERVIEW
4.1. Chapter Overview
4.2. Next Generation Contact Lenses: Overall Market Landscape
4.2.1. Distribution by Type of Developer
4.2.2. Distribution by Location of Headquarters of Developers
4.2.3. Distribution by Status of Development
4.2.4. Distribution by Target Indication
4.2.5. Distribution by Type of Product

4.3. Next Generation Contact Lenses: Market Landscape of Therapeutic Lenses
4.4. Next Generation Contact Lenses: Market Landscape of Drug-Eluting Lenses
4.5. Next Generation Contact Lenses: Market Landscape of Diagnostic / Monitoring Lenses

4.6. Visual Prostheses: Overall Market Landscape 
4.6.1. Distribution by Type of Developer
4.6.2. Distribution by Location of Headquarters of Developers
4.6.3. Distribution by Status of Development
4.6.4. Distribution by Target Indication
4.6.5. Distribution by Implant Site
4.7. Geographical Distribution of Stakeholder Players and KOLs

5. PROMOTIONAL ANALYSIS
5.1. Chapter Overview
5.2. An Overview of Channels Used for Promotional Campaigns
5.3. Channels Adopted by Industry Players for Promotional Campaigns
5.3.1. Product Website Analysis
5.3.2. Product Brochure Analysis
5.3.3. Product User Manual Analysis

5.4. ChromaGen™: Promotional Analysis
5.4.1. Product Overview
5.4.2. Product Website / Brochure Analysis
5.4.2.1. Messages for Healthcare Professionals
5.4.2.2. Messages for Patients

5.5. CUSTOMFLEX® ARTIFICIALIRIS: Promotional Analysis
5.5.1. Product Overview
5.5.2. Product Website / Brochure Analysis
5.5.2.1. Messages for Healthcare Professionals
5.5.2.2. Messages for Patients
5.5.2.3. Other Messages
5.5.3. Other Promotional Activities
5.5.3.1. Publication in Journals

5.6. EYEMATE®: Promotional Analysis
5.6.1. Product Overview
5.6.2. Product Website / Brochure Analysis
5.6.2.1. Messages for Healthcare Professionals
5.6.2.2. Messages for Patients
5.6.3. Other Promotional Activities
5.6.3.1. Publication in Journals

5.7. Hyper-CL™: Promotional Analysis
5.7.1. Product Overview
5.7.2. Product Website / Brochure Analysis
5.7.2.1. Messages for Healthcare Professionals
5.7.2.2. Messages for Patients
5.7.3. Product User Manual Analysis
5.7.3.1. Other Messages
5.7.4. Other Promotional Activities
5.7.4.1. Publication in Journals

5.8. Implantable Miniature Telescope: Promotional Analysis
5.8.1. Product Overview
5.8.2. Product Website / Brochure Analysis
5.8.2.1. Messages for Healthcare Professionals
5.8.2.2. Patient Access Program
5.8.2.3. Other Messages
5.8.3. Product User Manual Analysis
5.8.3.1. Messages for Patients
5.8.4. Other Promotional Activities
5.8.4.1. Publication in Journals

5.9. SENSIMED Triggerfish®: Promotional Analysis
5.9.1. Product Overview
5.9.2. Product Website / Brochure Analysis
5.9.2.1. Messages for Healthcare Professionals
5.9.2.2. Messages for Patients
5.9.3. Product User Manual Analysis
5.9.3.1. Other Messages
5.9.4. Other Promotional Activities
5.9.4.1. Publication in Journals
5.9.4.2. Presence in Conferences

6. TECHNOLOGY PROFILES
6.1. Chapter Overview
6.2. Next Generation Contact Lenses: Novel Technologies

6.3. EyePrintPRO™
6.3.1. Developer Overview
6.3.2. Technology Overview
6.3.2.1. Working Mechanism

6.4. Interscatter Communication Technology
6.4.1. Developer Overview
6.4.2. Technology Overview
6.4.2.1. Working Mechanism

6.5. Leo Lens Technology
6.5.1. Developer Overview
6.5.2. Technology Overview
6.5.2.1. Working Mechanism

6.6. Nanowafer Technology
6.6.1. Developer Overview
6.6.2. Technology Overview 
6.6.2.1. Working Mechanism

6.7. The Diamond Eye™ Technology
6.7.1. Developer Overview
6.7.2. Technology Overview
6.7.2.1. Working Mechanism

7. PATENT ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Next Generation Contact Lenses and Visual Prostheses: Patent Analysis
7.3.1. Analysis by Publication Year
7.3.2. Analysis by Geographical Location
7.3.3. Analysis by CPC Classification
7.3.4. Emerging Focus Areas
7.3.5. Leading Industry Players by Number of Patents
7.3.6. Leading Non-Industry Players by Number of Patents

7.4. Next Generation Contact Lenses and Visual Prostheses: Patent Benchmarking Analysis (Industry Players)
7.4.1. Analysis by CPC Classification
7.4.2. Analysis by Geography

7.5. Next Generation Contact Lenses and Visual Prostheses: Patent Benchmarking Analysis (Non-Industry Players)
7.5.1. Analysis by CPC Classification
7.5.2. Analysis by Geography
7.6. Next Generation Contact Lenses and Visual Prostheses: Patent Valuation Analysis

8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Next Generation Contact Lenses and Visual Prostheses: List of Partnerships and Collaborations
8.3.1. Analysis by Type of Partnership
8.3.2. Analysis by Type of Organization
8.3.3. Analysis by Area of Application
8.3.4. Analysis by Target Indication
8.3.5. Regional Analysis
8.3.5.1. Intercontinental and Intracontinental Agreements

9. EMERGING TRENDS ON SOCIAL MEDIA
9.1. Chapter Overview
9.2. Next Generation Contact Lenses and Visual Prostheses: Trends on Twitter
9.2.1. Social Media Analysis: Trending Words / Phrases Related to Next Generation     Contact Lenses and Visual Prostheses on Twitter
9.2.2. Social Media Analysis: Most Prolific Authors on Twitter

10. KOL ANALYSIS
10.1. Chapter Overview
10.2. Methodology
10.3. Principal Investigators / Sub-Investigators / Study Directors Involved in Clinical     Trials
10.3.1. Geographical Distribution
10.4. Prominent Key Opinion Leaders
10.5. KOL Benchmarking: Roots Analysis versus Third Party Scoring
10.6. Prominent Key Opinion Leaders
10.6.1. Profile: KOL A (Wills Eye Hospital)
10.6.2. Profile: KOL B (Retina Foundation of the Southwest)
10.6.3. Profile: KOL C (Rabin Medical Center)
10.6.4. Profile: KOL D (University of Oxford)
10.6.5. Profile: KOL E (New York Eye and Ear Infirmary)
10.6.6. Profile: KOL F (Fred Hutchinson Cancer Research Center)

11. MARKET SIZING AND FORECAST
11.1. Chapter Overview
11.2. Forecast Methodology 
11.3. Overall Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030
11.3.1. Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Product, 2019-2030
11.3.1.1. Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Lenses, 2019-2030
11.3.2. Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Target Indications, 2019-2030
11.3.3. Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Regions, 2019-2030

11.4. Next Generation Contact Lenses and Visual Prostheses Market in North America, 2019-2030
11.4.1. Next Generation Contact Lenses and Visual Prostheses Market in North America: Distribution by Type of Product, 2019-2030
11.4.1.1. Next Generation Contact Lenses and Visual Prostheses Market in North America: Contact Lenses, 2019-2030
11.4.1.1.1. Next Generation Contact Lenses and Visual Prostheses Market in North America: Therapeutic Lenses, 2019-2030
11.4.1.1.2. Next Generation Contact Lenses and Visual Prostheses Market in North America: Drug-Eluting Lenses, 2022-2030
11.4.1.1.3. Next Generation Contact Lenses and Visual Prostheses Market in North America: Diagnostic / Monitoring Lenses, 2019-2030
11.4.1.2. Next Generation Contact Lenses and Visual Prostheses Market in North America: Visual Prostheses, 2019-2030

11.4.2. Next Generation Contact Lenses and Visual Prostheses Market in North America: Distribution by Target Indication, 2019-2030
11.4.2.1. Next Generation Contact Lenses and Visual Prostheses Market in North America: Diabetes, 2025-2030
11.4.2.2. Next Generation Contact Lenses and Visual Prostheses Market in North America: Glaucoma, 2019-2030
11.4.2.3. Next Generation Contact Lenses and Visual Prostheses Market in North America: Age-related Macular Degeneration, 2019-2030
11.4.2.4. Next Generation Contact Lenses and Visual Prostheses Market in North America: Retinitis Pigmentosa, 2019-2030
11.4.2.5. Next Generation Contact Lenses and Visual Prostheses Market in North America: Aniridia, 2019-2030

11.5. Next Generation Contact Lenses and Visual Prostheses Market in EU5, 2019-2030
11.5.1. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Distribution by Type of Product, 2019-2030
11.5.1.1. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Contact Lenses, 2019-2030
11.5.1.1.1. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Therapeutic Lenses, 2019-2030
11.5.1.1.2. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Drug-Eluting Lenses, 2023-2030
11.5.1.1.3. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Diagnostic / Monitoring Lenses, 2019-2030
11.5.1.2. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Visual Prostheses, 2019-2030

11.5.2. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Distribution by Target Indication, 2019-2030
11.5.2.1. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Diabetes, 2026-2030
11.5.2.2. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Glaucoma, 2019-2030
11.5.2.3. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Age-related Macular Degeneration, 2019-2030
11.5.2.4. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Retinitis Pigmentosa, 2019-2030
11.5.2.5. Next Generation Contact Lenses and Visual Prostheses Market in EU5: Aniridia, 2019-2030

11.6. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific, 2019-2030
11.6.1. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Distribution by Type of Product, 2019-2030
11.6.1.1. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Contact Lenses, 2019-2030
11.6.1.1.1. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Therapeutic Lenses, 2019-2030
11.6.1.1.2. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Drug-Eluting Lenses, 2025-2030
11.6.1.1.3. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Diagnostic / Monitoring Lenses, 2020-2030
11.6.1.2. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific:  Visual Prostheses, 2019-2030

11.6.2. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Distribution by Target Indication, 2019-2030
11.6.2.1. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Diabetes, 2028-2030
11.6.2.2. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Glaucoma, 2020-2030
11.6.2.3. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Age-related Macular Degeneration, 2019-2030
11.6.2.4. Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Retinitis Pigmentosa, 2019-2030

12. INTERVIEW TRANSCRIPTS
12.1. Chapter Overview
12.2. EyeYon Medical
12.2.1. Interview Transcript: Michal Shavit, Head of Sales and Marketing

12.3. OcuMedic
12.3.1. Interview Transcript: Mark E. Byrne, Co-Founder and Chief Technical Officer
12.4. Leo Lens Technology
12.4.1. Interview Transcript: Praful Doshi, Founder, Chief Executive Officer and Chief Technical Officer

13. CONCLUSION
13.1. Advances in Ophthalmic Lens Technologies have Enabled the Development of Contact Lenses for Therapeutic, Bandage and Diagnostic Use 
13.2. The Competitive Landscape Features a Mix of Industry and Academic Players; Majority of Stakeholder are based in the US
13.3. Rising Interest in this Domain is Evident from Increasing Social Media Chatter and the Partnership Activity 
13.4. Technology Developers are Spearheading the Innovation, and Making Substantial     Contributions to the Intellectual Capital in this Field
13.5. Driven by Anticipated Growth in Target Population, coupled to the Ongoing Innovation, the Market is Likely to Witness Steady Growth over the Next Decade

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
 

 

List of Figures

Figure 3.1 Historical Evolution of Contact Lenses
Figure 3.2 Applications of Bandage Contact Lenses
Figure 3.3 Barriers to Ocular Drug Delivery
Figure 3.4 Novel Approaches for Corneal Drug Delivery
Figure 3.5 Steps Involved in Molecular Imprinting
Figure 3.6 Visual Prostheses: External and Implantable Modules
Figure 3.7 Visual Prostheses: Mode of Operation
Figure 3.8 Key Therapeutic Indications Targeting Contact Lenses and Visual Prostheses
Figure 4.1 Next Generation Contact Lenses: Distribution by Type of Developer
Figure 4.2 Next Generation Contact Lenses: Distribution by Type of Developer and Type of Contact Lenses
Figure 4.3 Next Generation Contact Lenses: Distribution by Location of Headquarters of Developer
Figure 4.4 Next Generation Contact Lenses: Distribution by Location of Headquarters of Developer and Type of Contact Lenses
Figure 4.5 Next Generation Contact Lenses: Distribution by Status of Development
Figure 4.6 Next Generation Contact Lenses: Distribution by Status of Development and Type of Contact Lenses
Figure 4.7 Next Generation Contact Lenses: Distribution by Target Indication
Figure 4.8 Next Generation Contact Lenses: Distribution by Target Indication and Type of Contact Lenses 
Figure 4.9 Next Generation Contact Lenses: Distribution by Type of Product
Figure 4.10 Visual Prostheses: Distribution by Type of Developer
Figure 4.11 Visual Prostheses: Distribution by Location of Headquarters of Developer
Figure 4.12 Visual Prostheses: Distribution by Status of Development
Figure 4.13 Visual Prostheses: Distribution by Target Indication
Figure 4.14 Visual Prostheses: Distribution by Implant Site 
Figure 4.15 Visual Prostheses: Logo Landscape of Bionic Eye Developers based on Implant Site
Figure 4.16 Next Generation Contact Lenses and Visual Prostheses: Geographical Distribution of Stakeholder Players and KOLs
Figure 5.1 Promotional Strategy: Channels Adopted for Promotional Campaigns
Figure 5.2 Promotional Strategy: Product Website Analysis
Figure 5.3 Promotional Strategy: Product Brochure Analysis
Figure 5.4 Promotional Strategy: Product User Manual Analysis
Figure 5.5 ChromaGen™ Product Website Analysis: Messages for Healthcare Professionals
Figure 5.6 ChromaGen™ Product Website Analysis: Messages for Patients
Figure 5.7 CUSTOMFLEX® ARTIFICIALIRIS Product Brochure Analysis: Warnings and     Precautions
Figure 5.8 CUSTOMFLEX® ARTIFICIALIRIS Product Website Analysis: Messages for             Patients
Figure 5.9 CUSTOMFLEX® ARTIFICIALIRIS Product Brochure Analysis: Other Messages
Figure 5.10 EYEMATE® Product Website Analysis: Messages for Healthcare Professionals
Figure 5.11 EYEMATE® Product Website Analysis: Key Advantages 
Figure 5.12 Hyper-CL™ Product Brochure Analysis: Messages for Healthcare Professionals
Figure 5.13 Hyper-CL™ Product Brochure Analysis: Messages for Healthcare Professionals, Comparative Study Results
Figure 5.14 Hyper-CL™ Product Website Analysis: Messages for Patients
Figure 5.15 Hyper-CL™ Product User Manual Analysis: Warnings and Precautions
Figure 5.16 Hyper-CL™ Product User Manual Analysis: General Instructions and Lens Handling Information
Figure 5.17 Implantable Miniature Telescope Product Brochure Analysis: Messages for Healthcare Professionals
Figure 5.18 Implantable Miniature Telescope Product Brochure Analysis: Reimbursement Information
Figure 5.19 Implantable Miniature Telescope Product Brochure Analysis: Other Messages
Figure 5.20 Implantable Miniature Telescope Product User Manual Analysis: Messages for Patients
Figure 5.21 SENSIMED Triggerfish® Product Website Analysis: Key Advantages
Figure 5.22 SENSIMED Triggerfish® Product Website Analysis: Messages for Healthcare Professionals
Figure 5.23 SENSIMED Triggerfish® Product Brochure Analysis: Data Visualization and Interpretation Information
Figure 5.24 SENSIMED Triggerfish® Product Website Analysis: Messages for Patients
Figure 5.25 SENSIMED Triggerfish® Product User Manual Analysis: Warnings and Precautions
Figure 5.26 SENSIMED Triggerfish® Product User Manual Analysis: Other Messages
Figure 6.1 Leo Lens Technology: Components
Figure 7.1 Patent Analysis: Distribution by Type of Patent
Figure 7.2 Patent Analysis: Cumulative Distribution by Publication Year, 2013-2018
Figure 7.3 Patent Analysis: Distribution by Geography
Figure 7.4 Patent Analysis: Distribution by CPC Classification
Figure 7.5 Patent Analysis: Emerging Focus Areas
Figure 7.6 Patent Analysis: Leading Industry Players
Figure 7.7 Patent Analysis: Leading Non-Industry Players
Figure 7.8 Patent Analysis (Industry Players): Number of Patents across Different Geographies
Figure 7.9 Patent Analysis (Industry Players): Benchmarking by International Patents
Figure 7.10 Patent Analysis (Non-Industry Players): Number of Patents across Different Geographies
Figure 7.11 Patent Analysis (Non-Industry Players): Benchmarking by International Patents
Figure 7.12 Patent Analysis: Distribution of Patents by Age (January 2013- Mid October 2018)
Figure 7.13 Patent Analysis: Valuation Analysis
Figure 8.1 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Organization
Figure 8.3 Partnerships and Collaborations: Distribution by Application Areas
Figure 8.4 Partnerships and Collaborations: Distribution by Target Indication
Figure 8.5 Partnerships and Collaborations: Regional Distribution
Figure 8.6 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
Figure 9.1 Social Media Analysis: Trending Words / Phrases on Twitter
Figure 9.2 Social Media Analysis: Trending Words / Phrases on Twitter Based on Focus Area
Figure 9.3 Social Media Analysis: Most Prolific Authors 
Figure 9.4 Social Media Analysis: Bubble Chart Analysis Based on Average Likes, Re-tweets and Comments Related to Next Generation Contact Lenses and Visual Prostheses, on Twitter
Figure 10.1 KOL Analysis: Geographical Distribution of Principal Investigators / Sub-Investigators / Study Directors
Figure 10.2 KOL Analysis: Dot-Plot of Principal Investigators
Figure 10.3 KOL Benchmarking: Roots Analysis versus Third Party Scoring
Figure 10.4 KOL Benchmarking: Roots Analysis versus Third Party Scoring (Scatter Plot)
Figure 10.5 KOL Analysis: Most Prominent Key Opinion Leaders
Figure 11.1 Overall Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030 (USD Million)
Figure 11.2 Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Product, 2019-2030 (USD Million)
Figure 11.3 Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Lenses, 2019-2030 (USD Million)
Figure 11.4 Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Target Indications, 2019-2030 (USD Million)
Figure 11.5 Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Regions, 2019-2030 (USD Million)
Figure 11.6 Next Generation Contact Lenses and Visual Prostheses Market in North America, 2019-2030 (USD Million)
Figure 11.7 Next Generation Contact Lenses and Visual Prostheses Market in North America: Contact Lenses, 2019-2030 (USD Million)
Figure 11.8 Next Generation Contact Lenses and Visual Prostheses Market in North America: Therapeutic Lenses, 2019-2030 (USD Million)
Figure 11.9 Next Generation Contact Lenses and Visual Prostheses Market in North America: Drug-Eluting Lenses, 2022-2030 (USD Million)
Figure 11.10 Next Generation Contact Lenses and Visual Prostheses Market in North America: Diagnostic / Monitoring Lenses, 2019-2030 (USD Million)
Figure 11.11 Next Generation Contact Lenses and Visual Prostheses Market in North America: Visual Prostheses, 2019-2030 (USD Million)
Figure 11.12 Next Generation Contact Lenses and Visual Prostheses Market in North America: Diabetes, 2025-2030 (USD Million)
Figure 11.13 Next Generation Contact Lenses and Visual Prostheses Market in North America: Glaucoma, 2019-2030 (USD Million)
Figure 11.14 Next Generation Contact Lenses and Visual Prostheses Market in North America: Age-related Macular Degeneration, 2019-2030 (USD Million)
Figure 11.15 Next Generation Contact Lenses and Visual Prostheses Market in North America; Retinitis Pigmentosa, 2019-2030 (USD Million)
Figure 11.16 Next Generation Contact Lenses and Visual Prostheses Market in North America: Aniridia, 2019-2030 (USD Million)
Figure 11.17 Next Generation Contact Lenses and Visual Prostheses Market in EU5, 2019-2030 (USD Million)
Figure 11.18 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Contact Lenses, 2019-2030 (USD Million)
Figure 11.19 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Therapeutic Lenses, 2019-2030 (USD Million)
Figure 11.20 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Drug-Eluting Lenses, 2023-2030 (USD Million)
Figure 11.21 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Diagnostic / Monitoring Lenses, 2019-2030 (USD Million)
Figure 11.22 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Visual Prostheses, 2019-2030 (USD Million)
Figure 11.23 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Diabetes, 2026-2030 (USD Million)
Figure 11.24 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Glaucoma, 2019-2030 (USD Million)
Figure 11.25 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Age-related Macular Degeneration, 2019-2030 (USD Million)
Figure 11.26 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Retinitis Pigmentosa, 2019-2030 (USD Million)
Figure 11.27 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Aniridia, 2019-2030 (USD Million)
Figure 11.28 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific, 2019-2030 (USD Million)
Figure 11.29 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Contact Lenses, 2019-2030 (USD Million)
Figure 11.30 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Therapeutic Lenses, 2019-2030 (USD Million)
Figure 11.31 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Drug-Eluting Lenses, 2025-2030 (USD Million)
Figure 11.32 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Diagnostic / Monitoring Contact Lenses, 2020-2030 (USD Million)
Figure 11.33 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Visual Prostheses, 2019-2030 (USD Million)
Figure 11.34 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Diabetes, 2028-2030 (USD Million)
Figure 11.35 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Glaucoma, 2020-2030 (USD Million)
Figure 11.36 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Age-related Macular Degeneration, 2019-2030 (USD Million)
Figure 11.37 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Retinitis Pigmentosa, 2019-2030 (USD Million)
Figure 13.1 Next Generation Contact Lenses: Logo Landscape of Developers across Different Regions, Type of Contact Lenses and Type of Organization
Figure 13.2 Overall Next Generation Ophthalmic Contact Lenses and Visual Prostheses Market, Conservative, Base and Optimistic Scenarios, 2019, 2025 and 2030 (USD Million)

List of Tables

Table 3.1 Advantages and Disadvantages of Different Types of Contact Lenses
Table 4.1 List of Next Generation Contact Lenses
Table 4.2 List of Therapeutic Contact Lenses
Table 4.3 List of Drug-Eluting Contact Lenses
Table 4.4 List of Diagnostic / Monitoring Contact Lenses
Table 4.5 List of Visual Prostheses
Table 5.1 ChromaGen™: Product Overview
Table 5.2 CUSTOMFLEX® ARTIFICIALIRIS: Product Overview
Table 5.3 EYEMATE®: Product Overview
Table 5.4 Hyper-CL™: Product Overview
Table 5.5 Implantable Miniature Telescope: Product Overview
Table 5.6 SENSIMED Triggerfish®: Product Overview
Table 5.7 Other Promotional Activities: Presence in Conferences
Table 6.1 List of Novel Technologies in Next Generation Contact Lens and Visual Prosthesis Market
Table 6.2 EyePrintPRO™: Technology Overview
Table 6.3 Interscatter Communication: Developer Overview
Table 6.4 Interscatter Communication: Technology Overview
Table 6.5 Leo Lens Technology: Developer Overview
Table 6.6 Leo Lens Technology: Technology Overview
Table 6.7 Nanowafer Technology: Developer Overview
Table 6.8 Nanowafer Technology: Technology Overview
Table 6.9 The Diamond Eye™ Technology: Developer Overview
Table 6.1 0The Diamond Eye™ Technology: Technology Overview
Table 7.1 Patent Analysis: Most Popular CPC Symbols 
Table 7.2 Patent Analysis: List of Top CPC Classifications
Table 7.3 Patent Analysis: Top Five CPC Classification Symbols (Johnson & Johnson Vision)
Table 7.4 Patent Analysis: Top Five CPC Classification Symbols (Novartis)
Table 7.5 Patent Analysis: Top Five CPC Classification Symbols (Allergan)
Table 7.6 Patent Analysis: Top Five CPC Classification Symbols (Transitions Optical)
Table 7.7 Patent Analysis: Top Five CPC Classification Symbols (Google)
Table 7.8 Patent Analysis: Top Five CPC Classification Symbols (Massachusetts General Hospital)
Table 7.9 Patent Analysis: Top Five CPC Classification Symbols (University of California)
Table 7.10 Patent Analysis: Top Five CPC Classification Symbols (Massachusetts Institute of Technology)
Table 7.11 Patent Analysis: Top Five CPC Classification Symbols (University of Colorado)
Table 7.12 Patent Analysis: Top Five CPC Classification Symbols (University of Illinois Ophthalmology)
Table 7.13 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 7.14 Patent Analysis: List of Leading Patents 
Table 8.1 Next Generation Contact Lenses and Visual Prostheses: Partnerships and Collaborations
Table 10.1 KOL Analysis: List of Principal Investigators / Sub-Investigators / Study Directors
Table 10.2 KOL Analysis: List of Universities and Hospitals
Table 10.3 KOL Analysis: Scoring System
Table 10.4 Profile: KOL A (Wills Eye Hospital)
Table 10.5 Profile: KOL B (Retina Foundation of the Southwest)
Table 10.6 Profile: KOL C (Rabin Medical Center)
Table 10.7 Profile: KOL D (University of Oxford)
Table 10.8 Profile: KOL E (New York Eye and Ear Infirmary)
Table 10.9 Profile: KOL F (Fred Hutchinson Cancer Research Center)
Table 11.1 Assumptions: Likely Prices of Different Types of Products
Table 11.2 Assumptions: Likely Adoption Rates of Different Types of Products
Table 14.1 Next Generation Contact Lenses: Distribution by Type of Developer
Table 14.2 Next Generation Contact Lenses: Distribution by Type of Developer and Type of Contact Lenses
Table 14.3 Next Generation Contact Lenses: Distribution by Location of Headquarters of Developer
Table 14.4 Next Generation Contact Lenses: Distribution by Location of Headquarters of Developers and Type of Contact Lenses
Table 14.5 Next Generation Contact Lenses: Distribution by Status of Development
Table 14.6 Next Generation Contact Lenses: Distribution by Status of Development and Type of Contact Lenses
Table 14.7 Next Generation Contact Lenses: Distribution by Target Indication
Table 14.8 Next Generation Contact Lenses: Distribution by Target Indication and Type of Contact Lenses
Table 14.9 Next Generation Contact Lenses: Distribution by Type of Product
Table 14.10 Visual Prostheses: Distribution by Type of Developer
Table 14.11 Visual Prostheses: Distribution by Location of Headquarters of Developer
Table 14.12 Visual Prostheses: Distribution by Status of Development
Table 14.13 Visual Prostheses: Distribution by Target Indication
Table 14.14 Visual Prostheses: Distribution by Implant Site
Table 14.15 Patent Analysis: Distribution by Type of Patent
Table 14.16 Patent Analysis: Cumulative Distribution by Publication Year, 2013-2018
Table 14.17 Patent Analysis: Distribution by Geography
Table 14.18 Patent Analysis: Leading Industry Players
Table 14.19 Patent Analysis: Leading Non-Industry Players
Table 14.20 Patent Analysis (Industry Players): Number of Patents Across Different Geographies
Table 14.21 Patent Analysis (Industry Players): Benchmarking by International Patents
Table 14.22 Patent Analysis (Non-Industry Players): Number of Patents Across Different Geographies
Table 14.23 Patent Analysis (Non-Industry Players): Benchmarking by International Patents
Table 14.24 Patent Analysis: Distribution of Patents by Age (January 2013- Mid October 2018)
Table 14.25 Partnerships and Collaborations: Distribution by Type of Partnership
Table 14.26 Partnerships and Collaborations: Distribution by Type of Organization
Table 14.27 Partnerships and Collaborations: Distribution by Application Areas
Table 14.28 Partnerships and Collaborations: Distribution by Target Indication
Table 14.29 Partnerships and Collaborations: Regional Distribution
Table 14.30 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
Table 14.31 Overall Next Generation Contact Lenses and Visual Prostheses Market, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.32 Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Product, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.33 Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Type of Contact Lenses, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.34 Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Target Indications, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.35 Next Generation Contact Lenses and Visual Prostheses Market: Distribution by Regions, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.36 Next Generation Contact Lenses and Visual Prostheses Market in North America, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.37 Next Generation Contact Lenses and Visual Prostheses Market in North America: Contact Lenses, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.38 Next Generation Contact Lenses and Visual Prostheses Market in North America: Therapeutic Lenses, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.39 Next Generation Contact Lenses and Visual Prostheses Market in North America: Drug-Eluting Lenses, Conservative, Base and Optimistic Scenario, 2022-2030 (USD Million)
Table 14.40 Next Generation Contact Lenses and Visual Prostheses Market in North America: Diagnostic / Monitoring Lenses, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.41 Next Generation Contact Lenses and Visual Prostheses Market in North America: Visual Prostheses, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.42 Next Generation Contact Lenses and Visual Prostheses Market in North America: Diabetes, Conservative, Base and Optimistic Scenario, 2025-2030 (USD Million)
Table 14.43 Next Generation Contact Lenses and Visual Prostheses Market in North America: Glaucoma, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.44 Next Generation Contact Lenses and Visual Prostheses Market in North America: Age-related Macular Degeneration, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.45 Next Generation Contact Lenses and Visual Prostheses Market in North America: Retinitis Pigmentosa, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.46 Next Generation Contact Lenses and Visual Prostheses Market in North America: Aniridia, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.47 Next Generation Contact Lenses and Visual Prostheses Market in EU5, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.48 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Contact Lenses, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.49 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Therapeutic Lenses, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.50 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Drug-Eluting Lenses, Conservative, Base and Optimistic Scenario, 2023-2030 (USD Million)
Table 14.51 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Diagnostic / Monitoring Lenses, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.52 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Visual Prostheses, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.53 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Diabetes, Conservative, Base and Optimistic Scenario, 2026-2030 (USD Million)
Table 14.54 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Glaucoma, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.55 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Age-related Macular Degeneration, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.56 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Retinitis Pigmentosa, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.57 Next Generation Contact Lenses and Visual Prostheses Market in EU5: Aniridia, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.58 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.59 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Contact Lenses, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.60 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Therapeutic Lenses, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.61 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Drug-Eluting Lenses, Conservative, Base and Optimistic Scenario, 2025-2030 (USD Million)
Table 14.62 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Diagnostic / Monitoring Contact Lenses, Conservative, Base and Optimistic Scenario, 2020-2030 (USD Million)
Table 14.63 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Visual Prostheses, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.64 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Diabetes, Conservative, Base and Optimistic Scenario, 2028-2030 (USD Million)
Table 14.65 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Glaucoma, Conservative, Base and Optimistic Scenario, 2020-2030 (USD Million)
Table 14.66 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Age-related Macular Degeneration, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)
Table 14.67 Next Generation Contact Lenses and Visual Prostheses Market in Asia-Pacific: Retinitis Pigmentosa, Conservative, Base and Optimistic Scenario, 2019-2030 (USD Million)

List of Companies

The following companies and organizations have been mentioned in the report.

  1. [W] Eye Clinic
  2. Aachen University Hospital
  3. Abbott Medical Optics
  4. Alcon 
  5. Alden Optical
  6. Alfred Hospital
  7. Allergan
  8. Applied Genetic Technologies 
  9. Assaf Harofeh Medical Center
  10. Associated Eye Care
  11. Bascom Palmer Eye Institute
  12. Baylor College of Medicine
  13. Bionic Sight
  14. Bionic Vision Technologies 
  15. Bionics Institute 
  16. Boston Children’s Hospital
  17. California Institute of Technology
  18. China Pharmaceutical University
  19. ChromaGen Vision
  20. Civil Aviation University of China
  21. Cleveland Clinic
  22. Clinic Saint Jean
  23. Cornea Consultants of Texas
  24. Dry Eye Center of Northeastern Pennsylvania
  25. Duke University School of Medicine
  26. Emory University
  27. Eye Associates of New Mexico 
  28. Eye Care of San Diego
  29. Eye Clinic Wittenbergplatz
  30. Eye Physicians of Long Beach
  31. Eye Specialty Group
  32. EyeGate Pharma
  33. EyePrint Prosthetics
  34. EyeYon Medical
  35. Fortis Memorial Research Institute
  36. Fred Hutchinson Cancer Research Center 
  37. Ghent University
  38. Google
  39. Grey Innovation
  40. Harvard Medical School
  41. Hospital Dresden-Friedrichstadt
  42. HumanOptics
  43. imec
  44. Implandata Ophthalmic Products
  45. Institute of Ocular Microsurgery
  46. Interojo
  47. Johannes Gutenberg University Mainz
  48. Johns Hopkins Wilmer Eye Institute
  49. Johnson & Johnson 
  50. K N Toosi University of Technology
  51. Karlsruhe Municipal Hospital
  52. King's College Hospital 
  53. Kish Healthcare Biotechnologies
  54. Klinikum rechts der Isar
  55. Knappschaftsklinikum Saar
  56. Korea Advanced Institute of Science and Technology
  57. Korea Institute of Science and Technology
  58. Kyungpook National University
  59. Leo Lens
  60. LG Innotek
  61. Loma Linda University Medical Center
  62. Massachusetts Eye and Ear Infirmary
  63. Massachusetts Institute of Technology
  64. Mayo Clinic
  65. Medella Health
  66. Mercy Clinic Eye Specialists
  67. Mid Atlantic Retina
  68. Minifab
  69. Minnesota Eye Consultants
  70. Monash University
  71. Moorfields Eye Hospital
  72. Nano Retina
  73. Nanovision Biosciences
  74. Nanyang Technological University
  75. Nara Institute of Science and Technology
  76. National Vision Research Institute
  77. New York Eye and Ear Infirmary
  78. NIDEK
  79. NJRetina
  80. Northwestern University
  81. Novartis
  82. OcuMedic
  83. OPHTEC
  84. Orange County Retina
  85. Oregon State University
  86. Osaka University
  87. PHI BioMed
  88. Pixium Vision
  89. Pohang University of Science and Technology 
  90. Poitiers University Hospital
  91. Poznan University of Medical Sciences
  92. Purdue University
  93. Queen's University Belfast
  94. Quinze-Vingts National Ophthalmology Hospital
  95. Rabin Medical Center
  96. Retina Consultants of Hawaii
  97. Retina Foundation of the Southwest
  98. Retina Implant
  99. Retinal Consultants of Arizona
  100. Royal Victorian Eye and Ear Hospital
  101. Sanglah General Hospital
  102. Sarasota Retina Institute
  103. Second Sight
  104. SEED
  105. Semmelweis University
  106. SENSIMED
  107. Seoul National University
  108. Sight Sciences
  109. Sightbox
  110. Southeast University
  111. St Paul's Eye Hospital
  112. Stony Brook University Hospital
  113. Swiss Federal Institute of Technology
  114. The University of Hong Kong
  115. Transitions Optical
  116. Tufts University School of Medicine
  117. Udayana University 
  118. Uka Tarsadia University
  119. Ulsan National Institute of Science and Technology
  120. UltraVision CLPL
  121. University Hospital of Würzburg
  122. University Health Network
  123. University Hospital Center of Bordeaux
  124. University Hospital Leipzig
  125. University Hospital Tuebingen
  126. University Hospital Zurich
  127. University Medical Center Hamburg-Eppendorf 
  128. University Medical Center Schleswig-Holstein
  129. University of Bern 
  130. University of Birmingham
  131. University of California
  132. University of Cologne
  133. University of Colorado
  134. University of Florida
  135. University of Houston
  136. University of Illinois
  137. University of Liverpool
  138. University of Maryland
  139. University of Melbourne
  140. University of Michigan Kellogg Eye Center 
  141. University of Minnesota
  142. University of North Carolina 
  143. University of Oxford
  144. University of Pittsburgh Medical Center
  145. University of Sydney
  146. University of Texas 
  147. University of Washington
  148. University of Waterloo
  149. Verily Life Sciences
  150. Veristat
  151. VisionCare Ophthalmic Technologies
  152. Wenzhou Medical College

Request Customization

Please select a suitable option for customization in the report

PRICING DETAILS

USD 4,499

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site / office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm / enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com